219 related articles for article (PubMed ID: 1827941)
21. Uptake of technetium-99m-teboroxime in cultured myocardial cells: comparison with thallium-201 and technetium-99m-sestamibi.
Maublant JC; Moins N; Gachon P; Renoux M; Zhang Z; Veyre A
J Nucl Med; 1993 Feb; 34(2):255-9. PubMed ID: 8429344
[TBL] [Abstract][Full Text] [Related]
22. Experimental studies of the physiologic properties of technetium-99m isonitriles.
Beller GA; Sinusas AJ
Am J Cardiol; 1990 Oct; 66(13):5E-8E. PubMed ID: 2145747
[TBL] [Abstract][Full Text] [Related]
23. [Myocardial scintigraphy with Tc-99m-teboroxime: its feasibility and the evaluation of its diagnostic reliability. A comparison with thallium-201 and coronary angiography].
Bisi G; Sciagrà R; Santoro GM; Cerisano G; Vella A; Zerauschek F; Fazzini PF
G Ital Cardiol; 1992 Jul; 22(7):795-805. PubMed ID: 1473653
[TBL] [Abstract][Full Text] [Related]
24. Preliminary report of SPECT imaging with Tc-99m teboroxime in ischemic heart disease.
Drane WE; Keim S; Strickland P; Tineo A; Nicole M
Clin Nucl Med; 1992 Mar; 17(3):215-25. PubMed ID: 1611794
[TBL] [Abstract][Full Text] [Related]
25. New directions in myocardial perfusion imaging.
Beller GA
Clin Cardiol; 1993 Feb; 16(2):86-94. PubMed ID: 8435933
[TBL] [Abstract][Full Text] [Related]
26. Technetium-99m teboroxime scintigraphy. Clinical experience in patients referred for myocardial perfusion evaluation.
Bontemps L; Geronicola-Trapali X; Sayegh Y; Delmas O; Itti R; André-Fouët X
Eur J Nucl Med; 1991; 18(9):732-9. PubMed ID: 1936049
[TBL] [Abstract][Full Text] [Related]
27. Comparison between technetium-99m-teboroxime and thallium-201 dipyridamole planar myocardial perfusion imaging in detection of coronary artery disease.
Labonté C; Taillefer R; Lambert R; Basile F; TonThat T; Jarry M; Léveillé J
Am J Cardiol; 1992 Jan; 69(1):90-6. PubMed ID: 1729873
[TBL] [Abstract][Full Text] [Related]
28. Technetium-99m sestamibi myocardial imaging: same-day rest-stress studies and dipyridamole.
Taillefer R
Am J Cardiol; 1990 Oct; 66(13):80E-84E. PubMed ID: 2145751
[TBL] [Abstract][Full Text] [Related]
29. Technetium-labeled myocardial imaging agents.
Iskandrian AS; Heo J
Int J Card Imaging; 1992; 8(4):277-87. PubMed ID: 1464728
[TBL] [Abstract][Full Text] [Related]
30. New agents labelled with technetium 99m for myocardial perfusion imaging.
Taillefer R
Can Assoc Radiol J; 1992 Aug; 43(4):258-66. PubMed ID: 1386280
[TBL] [Abstract][Full Text] [Related]
31. Myocardial perfusion imaging with technetium-99m-sestamibi: comparative analysis of available imaging protocols.
Berman DS; Kiat HS; Van Train KF; Germano G; Maddahi J; Friedman JD
J Nucl Med; 1994 Apr; 35(4):681-8. PubMed ID: 8151394
[TBL] [Abstract][Full Text] [Related]
32. Tomographic myocardial perfusion imaging with technetium-99m teboroxime during adenosine-induced coronary hyperemia: correlation with thallium-201 imaging.
Iskandrian AS; Heo J; Nguyen T; Beer S; Cave V; Cassel D; Iskandrian BB
J Am Coll Cardiol; 1992 Feb; 19(2):307-12. PubMed ID: 1732357
[TBL] [Abstract][Full Text] [Related]
33. Use of technetium-99m sestamibi to determine the size of the myocardial area perfused by a coronary artery.
Braat SH; de Swart H; Janssen JH; Brugada P; Rigo P; Wellens HJ
Am J Cardiol; 1990 Oct; 66(13):85E-90E. PubMed ID: 2145752
[TBL] [Abstract][Full Text] [Related]
34. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous measurement of ventricular function and myocardial perfusion using the technetium-99m isonitriles.
Sporn V; Perez Balino N; Holman BL; Sosa Liprandi A; Masoli O; Mitta A; Camin LL; Castiglia S; McKusick KA
Clin Nucl Med; 1988 Feb; 13(2):77-81. PubMed ID: 3349720
[TBL] [Abstract][Full Text] [Related]
36. Physiologic properties of myocardial perfusion tracers.
Dahlberg ST; Leppo JA
Cardiol Clin; 1994 May; 12(2):169-85. PubMed ID: 8033171
[TBL] [Abstract][Full Text] [Related]
37. Measurement of myocardial blood flow using a co-injection technique for technetium-99m-teboroxime, technetium-96-sestamibi and thallium-201.
Di Rocco RJ; Rumsey WL; Kuczynski BL; Linder KE; Pirro JP; Narra RK; Nunn AD
J Nucl Med; 1992 Jun; 33(6):1152-9. PubMed ID: 1534576
[TBL] [Abstract][Full Text] [Related]
38. Myocardial SPECT and left ventricular performance study using a single Tc-99m teboroxime injection. Comparison with thallium-201 myocardial SPECT.
Oshima M; Ishihara M; Ohno M; Hayase S; Yokota M; Ando A; Akanabe H; Ito K; Sakuma S
Clin Nucl Med; 1993 Oct; 18(10):844-51. PubMed ID: 8242976
[TBL] [Abstract][Full Text] [Related]
39. Quantification of left ventricular function with thallium-201 and technetium-99m-sestamibi myocardial gated SPECT.
Maunoury C; Chen CC; Chua KB; Thompson CJ
J Nucl Med; 1997 Jun; 38(6):958-61. PubMed ID: 9189150
[TBL] [Abstract][Full Text] [Related]
40. Technetium-99m-labeled myocardial perfusion agents: Are they better than thallium-201?
Kailasnath P; Sinusas AJ
Cardiol Rev; 2001; 9(3):160-72. PubMed ID: 11304401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
